Our webinar discusses key near-term trends and regulations and investigate persistent challenges frequently throwing even the most efficient teams off track. Advarra and industry representatives will dive deeper into achieving critical milestones across study startup, conduct, and close out that every project manager should optimize.
Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials Clinical trials are no longer static. Over the
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when that complexity creates friction in
Over the last 15 to 20 years, monoclonal antibody-based treatments, such as those targeting vascular endothelial growth factor (anti-VEGF), have
Why we exist Oncology research is moving quickly, and study teams face mounting complexity: novel modalities, new data tools, shifting
Clinical trial study design forms the foundation of trial success. The decisions teams make at the design stage shape how
Fueled by automation to remove one of the biggest barriers to adoption Increasingly, research sites are not just asking how
AI is becoming a routine part of how research proposals are prepared and reviewed, from drafting applications to supporting administrative
For nearly a decade, Francine Lopez has helped clinical research move from idea to impact. From her early days at
Our webinar discusses key near-term trends and regulations and investigate persistent challenges frequently throwing even the most efficient teams off track. Advarra and industry representatives will dive deeper into achieving critical milestones across study startup, conduct, and close out that every project manager should optimize.
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
